ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: This study aimed to evaluate lncRNAs as potential biomarkers in CML by comparing the transcriptomes of CML patients with high levels of BCR::ABL1 transcripts to those of healthy donors.